Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series
- PMID: 38856325
- PMCID: PMC11379633
- DOI: 10.1093/oncolo/oyae114
Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series
Abstract
Background: The incidence of breast and colorectal cancer (CRC) in younger-than-average-age patients is rising and poorly understood. This is the largest study on patients with both cancers who are less than 60 years old and aims to characterize demographic, clinicopathologic, and genetic features and describe therapeutic dilemmas and management strategies.
Materials and methods: This is a retrospective medical records review of patients at the University of California San Francisco with both primary breast and CRC before age 60.
Results: Fifty-one patients were identified; 41 had detailed medical records. Median age of diagnosis with breast cancer was 43 (range 27-59) and CRC was 50 (28-59). Most were Caucasian (38, 74.5%) and never smokers (23, 56.1%); about half were current alcohol consumers (20, 48.8%) and about one-third had sedentary jobs (14, 34.1%). Average BMI was 25.8 (range: 14-49), and 30% were overweight or obese. Breast was the first cancer diagnosed in 36 patients (70.6%) and 44 (86.3%) had a metachronous CRC diagnosis. Breast cancer was early stage (0-2) in 32 (78.0%) patients whereas CRC was split between early stage (1-2) in 14 (34.1%) and later stage (3-4) in 19 (46.2%). Ten patients (24.3%) had a known germline mutation, although 23 (56.1%) had a family history of cancer in a first-degree relative.
Conclusion: Younger patients with both breast and CRC are a unique cohort, often without known risk factors. Alcohol consumption and sedentary jobs were the most common risk factors, and about one-quarter had a known genetic predisposition. Comanagement of both cancers requires individualized, multidisciplinary care.
Keywords: breast cancer; colorectal; genetic; young.
© The Author(s) 2024. Published by Oxford University Press.
Conflict of interest statement
No relevant conflicts of interest exist for the authors.
Figures
Similar articles
-
Clinicopathologic features and prognosis of synchronous and metachronous multiple primary colorectal cancer.Clin Transl Oncol. 2021 Feb;23(2):335-343. doi: 10.1007/s12094-020-02426-3. Epub 2020 Jun 26. Clin Transl Oncol. 2021. PMID: 32592156
-
Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.Eur J Surg Oncol. 2021 May;47(5):1026-1033. doi: 10.1016/j.ejso.2020.11.135. Epub 2020 Nov 26. Eur J Surg Oncol. 2021. PMID: 33272737
-
Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.Clin Gastroenterol Hepatol. 2014 Dec;12(12):2078-84.e1-2. doi: 10.1016/j.cgh.2014.04.017. Epub 2014 Apr 24. Clin Gastroenterol Hepatol. 2014. PMID: 24768809
-
Bilateral Breast Cancer.Am Surg. 2025 May;91(5):854-858. doi: 10.1177/00031348251323713. Epub 2025 Feb 21. Am Surg. 2025. PMID: 39982251 Review.
-
Melanoma and Colorectal Cancer as Second Primary Cancers: A Scoping Review of Their Association and the Underlying Biological, Lifestyle, and Genetic Factors.J Gastrointest Cancer. 2025 May 31;56(1):125. doi: 10.1007/s12029-024-01114-7. J Gastrointest Cancer. 2025. PMID: 40447784 Free PMC article.
Cited by
-
Synchronous Breast and Colorectal Malignant Tumors-A Systematic Review.Life (Basel). 2024 Aug 13;14(8):1008. doi: 10.3390/life14081008. Life (Basel). 2024. PMID: 39202750 Free PMC article. Review.
References
-
- Cancer of the breast (female) - Cancer Stat Facts. SEER. Accessed February 24, 2022. https://seer.cancer.gov/statfacts/html/breast.html
-
- Cancer of the colon and rectum - Cancer Stat Facts. SEER. Accessed February 24, 2022. https://seer.cancer.gov/statfacts/html/colorect.html